Boehringer and Eli Lilly have started a large-scale trial of their diabetes drug Jardiance in acute heart failure, seeking to get ahead of rivals such as AstraZeneca. The new study - called ...
Boehringer Ingelheim and Eli Lilly have the results they were hoping for in a large-scale study of Jardiance therapy in heart failure with preserved ejection fraction (HFpEF), a form of chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback